Conference abstractPublished 5 Sep 2016
New benzimidazole-hydrazones as MAO inhibitors
Anadolu University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Monoamine oxidase inhibitors (MAOIs) are agents, which inhibit the activity of the monoamine oxidase (MAO) enzymes. These drugs possess a long history of use as medications proposed for the treatment of depression. MAOIs are especially effective in the control of atypical depression. MAO-B inhibitors are also preferred in the treatment of ParkinsonâÂ?Â?s disease. Propargyl moiety is an important pharmacophoric group which presents in the chemical structures of MAO inhibitors as selegiline and rasagiline. Hydrazone is another essential functional group in terms of MAO inhibition. Thus, in the present study some new benzimidazole compounds bearing propargyl and hydrazone side chains were synthesized. Structures of the synthesized compounds were evaluated by IR, 1H-NMR, 13C-NMR and Mass spectroscopic methods. Effects of the synthesized compounds on MAO enzymes were observed by using kynuramine based in-vitro fluorimetric method. Activity studies revealed that synthesized compounds have more selectivety against MAO-B enzyme.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ozgur Devrim CAN”
- BylineArticles whose byline prints “Umide DEMIR UZKAY”
- BylineArticles whose byline prints “Derya OSMANIYE”
- BylineArticles whose byline prints “Begum Nurpelin SAILIK”
